{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:15:20Z","timestamp":1780715720151,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ijpharm.2017.08.112","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T17:45:50Z","timestamp":1504115150000},"page":"328-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ipratropium is \u2018luminally recycled\u2019 by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers"],"prefix":"10.1016","volume":"532","author":[{"given":"Vijender","family":"Panduga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bosquillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijpharm.2015.10.036","article-title":"Absorption of ipratropium and l-carnitine into the pulmonary circulation of the ex-vivo rat lung is driven by passive processes rather than active uptake by OCT\/OCTN transporters","volume":"496","author":"Al-Jayyoussi","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.08.112_bib0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0703078","article-title":"Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism","volume":"129","author":"Bleasby","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"10\u201311","key":"10.1016\/j.ijpharm.2017.08.112_bib0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00498250600861751","article-title":"Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition","volume":"36","author":"Bleasby","year":"2006","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.ijpharm.2017.08.112_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11095-006-0251-4","article-title":"Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein","volume":"23","author":"Bourdet","year":"2006","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/hsz-2016-0236","article-title":"Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families","volume":"398","author":"Chen","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijpharm.2017.08.112_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00609193","article-title":"Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration","volume":"2","author":"Ensing","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.08.112_bib0040","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017. Available from: http:\/\/goldcopd.org."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.08.112_bib0045","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.08.112_bib0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.114.220350","article-title":"Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers","volume":"352","author":"Han","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"18","key":"10.1016\/j.ijpharm.2017.08.112_bib0055","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1021\/jm400966v","article-title":"Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2","volume":"56","author":"Hendrickx","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.08.112_bib0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcph.215","article-title":"Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease","volume":"54","author":"Hohlfeld","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.08.112_bib0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2013.06.010","article-title":"Digoxin net secretory transport in bronchial epithelial cell layers is not exclusively mediated by P-glycoprotein\/MDR1","volume":"86","author":"Hutter","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.08.112_bib0070","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bbamem.2015.04.001","article-title":"Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells","volume":"1848","author":"Ingoglia","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbamem.2015.11.013","article-title":"Functional activity of L-carnitine transporters in human airway epithelial cells","volume":"1858","author":"Ingoglia","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ijpharm.2017.08.112_bib0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejps.2005.11.011","article-title":"Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein","volume":"27","author":"Keogh","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.08.112_bib0085","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.08.112_bib0090","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/js980474k","article-title":"Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers","volume":"88","author":"Lee","year":"1999","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.08.112_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/bdd.280","article-title":"Pharmacokinetics and tissue distribution of the anticholinergics tiotropium and ipratropium in the rat and dog","volume":"22","author":"Leusch","year":"2001","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.08.112_bib0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10611860290007504","article-title":"Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats","volume":"10","author":"Mathia","year":"2002","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.08.112_bib0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12272-015-0704-6","article-title":"Functional and cytometric examination of different human lung epithelial cell types as drug transport barriers","volume":"39","author":"Min","year":"2016","journal-title":"Arch. Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.08.112_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2011.12.036","article-title":"Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro","volume":"426","author":"Mukherjee","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vascn.2013.05.007","article-title":"In-cell Western\u2122 detection of organic cation transporters in bronchial epithelial cell layers cultured at an air-liquid interface on Transwell\u00ae inserts","volume":"68","author":"Mukherjee","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6","key":"10.1016\/j.ijpharm.2017.08.112_bib0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bcp.2013.07.008","article-title":"Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine","volume":"86","author":"Muller","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.08.112_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/mp900206j","article-title":"Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation\/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption","volume":"7","author":"Nakamura","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.08.112_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/dmd.110.035402","article-title":"Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans","volume":"39","author":"Nakanishi","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.ijpharm.2017.08.112_bib0135","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1002\/jps.23603","article-title":"In vivo evidence of organic cation transporter-mediated tracheal accumulation of the anticholinergic agent ipratropium in mice","volume":"102","author":"Nakanishi","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.08.112_bib0140","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00204-016-1728-5","article-title":"Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine","volume":"90","author":"Nies","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.ijpharm.2017.08.112_bib0145","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1517\/17425247.2013.805743","article-title":"Pharmaceutical applications of the Calu-3 lung epithelia cell line","volume":"10","author":"Ong","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"50","key":"10.1016\/j.ijpharm.2017.08.112_bib0150","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A human transporter protein that mediates the final excretion step for toxic organic cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.xphs.2015.11.040","article-title":"Why does the intestine lack basolateral efflux transporters for cationic compounds? A provocative hypothesis","volume":"105","author":"Proctor","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijpharm.2017.08.112_bib0160","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1002\/jps.23606","article-title":"Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry","volume":"102","author":"Sakamoto","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.08.112_bib0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1146\/annurev.pharmtox.44.101802.121444","article-title":"Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs","volume":"45","author":"Shitara","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.08.112_bib0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0091270003261315","article-title":"Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment","volume":"44","author":"Turck","year":"2004","journal-title":"J. Clin. Pharmacol."},{"issue":"20","key":"10.1016\/j.ijpharm.2017.08.112_bib0175","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2174\/092986708785132870","article-title":"Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development","volume":"15","author":"Zhou","year":"2008","journal-title":"Curr. Med. Chem."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317308311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317308311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T21:00:39Z","timestamp":1536267639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317308311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0378517317308311"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.112","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ipratropium is \u2018luminally recycled\u2019 by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}